search icon
      blog search icon

      Should you invest in Motus G.I. Holdings, Inc. (MOTS) stock? - Stocks Telegraph

      By Shan Zee

      Published on

      March 16, 2021

      7:06 PM UTC

      Last Updated on

      October 21, 2021

      9:38 AM UTC

      Should you invest in Motus G.I. Holdings, Inc. (MOTS) stock? - Stocks Telegraph

      Motus G.I. Holdings, Inc. (MOTS) will be releasing their latest earnings report sometime TODAY. Analysts have predicted that Motus G.I. Holdings will report a loss of $0.13 per share on revenue of $70 thousand.

      About Motus G.I. Holdings, Inc.

      Motus G.I. Holdings, Inc. is a U.S. based medical technology company, having its subsidiaries in Israel and the United States. The company has dedicated itself to enhance the cost-efficiency of colonoscopy and the improvement of clinical outcomes. Motus G.I. holding’s star product is the Pure-Vu system. It is a device approved by the U.S. Food and Drug Administration (FDA) that helps facilitate the cleaning of the colon that is poorly prepared during the colonoscopy procedure and is designed to help detect colorectal cancer in early stages and other colon and rectum related diseases. The device assimilates with colonoscopies that enable it to provide safe and rapid cleansing during the colonoscopy procedure while preserving the already established procedural workflow and techniques. There are approximately 1.5 million annual colonoscopy procedures in the U.S. and almost 4 million worldwide. The challenges for inpatient colonoscopy represent a vast area of unmet need that increases the cost of care and directly affects the clinical outcomes. Motus G.I. believes that their product will help revolutionize colonoscopy procedures and improve the results.
      Motus Holdings has announced that the first patient has been enrolled in a pilot study of their product Pure-Vu system conducted by a leading medical center in the United States. The study is further expected to enroll 20 more patients.

      MOTS stock performance

      Analysts have predicted that MOTS will report a per-share loss of $0.13 on the revenue of $70 thousand. In contrast to the same quarter last year, MOTS reported earnings per share of $0.21 on revenue of $99 thousand. If MOTS is to report the earnings consistent with that predicted, the sales will go down by 29.29% from the year-ago period, and the quarterly profit would increase 38.1%. The past analysts’ predictions regarding the earning per share have been pretty close. MOTS stock has gone up 185.76% over the last year. Provided that these returns are usually positive, the long-term shareholders need not worry about the MOTS earnings release.

      More From Stocks telegraph